Immucor’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Immucor is a provider of transfusion and transplantation diagnostic products that generates and connects right match of donors with patients. Read more

166 Followers on Owler
166 Followers on Owler
166 Followers on Owler
166 Followers on Owler

Immucor is a provider of transfusion and transplantation diagnostic products that generates and connects right match of donors with patients. Read more

Avi Pelossof's photo - President & CEO of Immucor

President & CEO

Avi Pelossof

CEO Approval Rating

59/100

Founded:

1982

Status:

PrivateSubsidiary of IVD Holdings, Inc.

Est. Annual Revenue
Est. Employees
Sector

Update Industry

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

BioMerieux is perceived as one of Immucor's biggest rivals. BioMerieux was founded in 1963, and is headquartered in Marcy L'etoile, Auvergne. BioMerieux is in the Biotechnology industry. BioMerieux generates $2.9B more revenue vs. Immucor.

Vitro Biopharma is a top competitor of Immucor. Vitro Biopharma is a Public company that was founded in 1986 in Golden, Colorado. Vitro Biopharma operates in the Pharmaceuticals industry. Compared to Immucor, Vitro Biopharma has 1,046 fewer employees.

Surmodics, Inc. is Immucor's #3 rival. Surmodics, Inc. is headquartered in Eden Prairie, Minnesota, and was founded in 1979. Surmodics, Inc. competes in the Health Care Equipment industry. Surmodics, Inc. generates 27% the revenue of Immucor.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 1,050 a good estimate for Immucor's Employee count?

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

-

Oct 2014

Source »
undisclosed
-

These are all the companies that Immucor has acquired. Immucor's latest acquisition was in Oct 2014.

Investments

No recent investments found related to Immucor

These are all the companies that Immucor has invested in. Immucor's latest investment was in Oct 2014.

Immucor News

November 8, 20184-traders

Immucor Announces FDA Clearance for NEO Iris ; Next Generation, Fully Automated Instrument for Transfusion Medicine

(marketscreener.com) Highest throughput for immunohematology now powered with clearer results for bri... See more »
November 1, 2018BioPortfolio

Immucor Inc. Medical Equipment Deals and Alliances Profile Report Updated 16102018 Prices from USD $250

SummaryImmucor Inc. Immucor is an invitro diagnostics company which specializes in the area of pretra... See more »
August 17, 2018BioPortfolio

Immucor Inc. Strategic SWOT Analysis Review Report Updated 25042018 Prices from USD $125

Immucor Inc. Strategic SWOT Analysis Review provides a comprehensive insight into the company's histo... See more »
March 4, 2018BioPortfolio

Immucor Inc. Medical Equipment Deals and Alliances Profile Report Updated 13022018 Prices from USD $250

SummaryImmucor Inc. Immucor is an invitro diagnostics company which specializes in the area of pretra... See more »
January 16, 2018ClinicaSpace

Immucor Names Former Alere Exec as New CEO

Pelossof joins Immucor from Alere, where he was most recently Global President for the Infectious Dis... See more »
December 13, 2017BioPortfolio

Immucor Inc. Strategic SWOT Analysis Review Report Updated 29112017 Prices from USD $125

Immucor Inc. Strategic SWOT Analysis Review provides a comprehensive insight into the company's histo... See more »

Immucor Press Releases

June 27, 2017Press Release Rocket

Mediaplanet Partners Up with Immucor for Transplants Campaign

Immucor helps lead the way for both transplant surgeons and patients needing organs desperately. New ... See more »
December 9, 2016openPR

Global Immunohematology Market to grow at a CAGR of 4.79% during 2016-2020

About Immunohematology Blood loss or anemia can lead to chronic health problems; therefore, clinician... See more »
December 8, 2016Free Press Release Center

Global Blood Transfusion Diagnostics Market Overview, Growth, Supply, Revenue And Forecast 2016-2027

Global Blood Transfusion Diagnostics Market Information by Type (Instruments, Reagents), By Applicati... See more »
November 4, 2016Market Press Release

Transfusion Diagnostic Equipment Market Research Report 2016

The Global And China Transfusion Diagnostic Equipment Industry 2016 Market Research Report is a profe... See more »

Immucor Videos

Social Media

Headquarters

3130 Gateway Drive

Norcross, Georgia30091

855-466-8267

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Immucor is a provider of transfusion and transplantation diagnostic products that generates and connects right match of donors with patients. Immucor was founded in 1982. Immucor's headquarters is located in Norcross, Georgia, USA 30091. Immucor's lat...

CEO

Immucor's President & CEO, Avi Pelossof, currently has an approval rating of 59%. Immucor's primary competitors are BioMerieux, Vitro Biopharma & Surmodics, Inc..

Website

immucor.com

Frequently Asked Questions about Immucor

  1. When was Immucor founded?

    Immucor was founded in 1982
  2. Who is Immucor's CEO?

    Immucor's CEO is Avi Pelossof
  3. How much revenue does Immucor generate?

    Immucor generates $380M in revenue
  4. How much funding does Immucor have?

    Immucor has historically raised $0 in funding
  1. Where is Immucor's headquarters?

    Immucor's headquarters is in Norcross Georgia, USA
  2. How many employees does Immucor have?

    Immucor has 1,050 employees
  3. Who are Immucor's competitors?

    Immucor's top competitors are BioMerieux, Vitro Biopharma, Surmodics, Inc.